{
    "protocolSection": {
        "identificationModule": {
            "nctId": "NCT06365853",
            "orgStudyIdInfo": {
                "id": "IMGN853-0424"
            },
            "secondaryIdInfos": [
                {
                    "id": "2023-505617-24-00",
                    "type": "CTIS"
                }
            ],
            "organization": {
                "fullName": "ImmunoGen, Inc.",
                "class": "INDUSTRY"
            },
            "briefTitle": "A Study of Ocular Toxicity Evaluation and Mitigation During Treatment With Mirvetuximab Soravtansine in Participants With Recurrent Ovarian Cancer With High Folate Receptor-Alpha Expression",
            "officialTitle": "A Randomized Phase 2 Study of Ocular Toxicity Evaluation and Mitigation During Treatment With Mirvetuximab Soravtansine in Patients With Recurrent Ovarian Cancer With High Folate Receptor-Alpha Expression",
            "therapeuticArea": [
                "Oncology and Hematology",
                "Other"
            ],
            "study": "a-study-of-ocular-toxicity-evaluation-and-mitigation-during-treatment-with-mirvetuximab-soravtansine-in-participants-with-recurrent-ovarian-cancer-with-high-folate-receptor-alpha-expression"
        },
        "statusModule": {
            "statusVerifiedDate": "2024-04",
            "overallStatus": "NOT_YET_RECRUITING",
            "expandedAccessInfo": {
                "hasExpandedAccess": false
            },
            "startDateStruct": {
                "date": "2024-06-30",
                "type": "ESTIMATED"
            },
            "primaryCompletionDateStruct": {
                "date": "2026-05-26",
                "type": "ESTIMATED"
            },
            "completionDateStruct": {
                "date": "2027-05-26",
                "type": "ESTIMATED"
            },
            "studyFirstSubmitDate": "2024-04-10",
            "studyFirstSubmitQcDate": "2024-04-10",
            "studyFirstPostDateStruct": {
                "date": "2024-04-15",
                "type": "ACTUAL"
            },
            "lastUpdateSubmitDate": "2024-04-10",
            "lastUpdatePostDateStruct": {
                "date": "2024-04-15",
                "type": "ACTUAL"
            }
        },
        "sponsorCollaboratorsModule": {
            "responsibleParty": {
                "type": "SPONSOR"
            },
            "leadSponsor": {
                "name": "ImmunoGen, Inc.",
                "class": "INDUSTRY"
            }
        },
        "oversightModule": {
            "oversightHasDmc": false,
            "isFdaRegulatedDrug": true,
            "isFdaRegulatedDevice": false
        },
        "descriptionModule": {
            "briefSummary": "The purpose of this study is to evaluate the incidence rate and severity of pre-specified mirvetuximab soravtansine (MIRV)-related ocular treatment-emergent adverse events (TEAEs) and assess prophylaxis strategies in all participants (symptomatic and asymptomatic) undergoing prospective ophthalmic evaluation with recurrent ovarian cancer (participants with either platinum-sensitive ovarian cancer \\[PSOC\\] or platinum-resistant ovarian cancer \\[PROC\\]) with high folate receptor alpha (FR\u03b1) expression.",
            "detailedDescription": "Participants will be randomized (1:1) to 1 of 2 ocular adverse event (AE) risk mitigation strategy arms (primary prophylactic steroid eye drops versus primary prophylactic vasoconstricting eye drops)."
        },
        "conditionsModule": {
            "conditions": [
                "Recurrent Ovarian Cancer",
                "Folate Receptor-Alpha Positive"
            ]
        },
        "designModule": {
            "studyType": "INTERVENTIONAL",
            "phases": [
                "PHASE2"
            ],
            "designInfo": {
                "allocation": "RANDOMIZED",
                "interventionModel": "PARALLEL",
                "primaryPurpose": "TREATMENT",
                "maskingInfo": {
                    "masking": "NONE"
                }
            },
            "enrollmentInfo": {
                "count": 100,
                "type": "ESTIMATED"
            }
        },
        "armsInterventionsModule": {
            "armGroups": [
                {
                    "label": "Primary Prophylactic Steroid Eye Drops",
                    "type": "EXPERIMENTAL",
                    "description": "Prednisolone acetate ophthalmic suspension 1% 6 times daily on Days -1 to 4 and 4 times daily (QID) on Days 5 to 8 of each cycle; Lubricating eye drops QID throughout the entire cycle (doses should follow steroid dosing, when given, by approximately 15 minutes); MIRV 6 milligrams (mg)/kilogram (kg) adjusted ideal body weight (AIBW) every 3 weeks (Q3W). Each cycle length = 21 days.",
                    "interventionNames": [
                        "Drug: Mirvetuximab Soravtansine",
                        "Drug: Lubricating Eye Drops",
                        "Drug: Prednisolone acetate ophthalmic suspension 1% eye drops"
                    ]
                },
                {
                    "label": "Primary Prophylactic Vasoconstricting Eye Drops",
                    "type": "EXPERIMENTAL",
                    "description": "Primary prophylactic brimonidine tartrate ophthalmic solution eye drops 3 times daily (TID) throughout the cycle; Lubricating eye drops QID throughout the entire cycle (doses should follow brimonidine dosing, when given, by approximately 15 minutes); MIRV 6 mg/kg AIBW Q3W. Each cycle length = 21 days.",
                    "interventionNames": [
                        "Drug: Mirvetuximab Soravtansine",
                        "Drug: Lubricating Eye Drops",
                        "Drug: Brimonidine tartrate ophthalmic solution eye drops"
                    ]
                }
            ],
            "interventions": [
                {
                    "type": "DRUG",
                    "name": "Mirvetuximab Soravtansine",
                    "description": "Mirvetuximab soravtansine is an antibody drug conjugate designed to target folate receptor \u03b1 (FR\u03b1). It consists of the humanized anti-FR\u03b1 monoclonal antibody (mAb) M9346A attached via a cleavable disulfide linker to the cytotoxic maytansinoid, DM4.",
                    "armGroupLabels": [
                        "Primary Prophylactic Steroid Eye Drops",
                        "Primary Prophylactic Vasoconstricting Eye Drops"
                    ],
                    "otherNames": [
                        "IMGN853",
                        "MIRV"
                    ]
                },
                {
                    "type": "DRUG",
                    "name": "Lubricating Eye Drops",
                    "description": "Lubricating artificial tears should be administered at least 15 minutes after corticosteroid or brimonidine eye drop administration.",
                    "armGroupLabels": [
                        "Primary Prophylactic Steroid Eye Drops",
                        "Primary Prophylactic Vasoconstricting Eye Drops"
                    ]
                },
                {
                    "type": "DRUG",
                    "name": "Prednisolone acetate ophthalmic suspension 1% eye drops",
                    "description": "Self-administration of prednisolone acetate ophthalmic suspension 1% eye drops as prescribed by the treating physician.",
                    "armGroupLabels": [
                        "Primary Prophylactic Steroid Eye Drops"
                    ]
                },
                {
                    "type": "DRUG",
                    "name": "Brimonidine tartrate ophthalmic solution eye drops",
                    "description": "Self-administration of brimonidine tartrate ophthalmic solution eye drops as prescribed by the treating physician.",
                    "armGroupLabels": [
                        "Primary Prophylactic Vasoconstricting Eye Drops"
                    ]
                }
            ]
        },
        "outcomesModule": {
            "primaryOutcomes": [
                {
                    "measure": "Number of Participants With MIRV-related Corneal AEs (\u2265 Grade 2) in Asymptomatic Participants",
                    "description": "This endpoint will be assessed in the participants receiving MIRV who are asymptomatic (defined as ocular symptom assessment \u2264 Grade 1), in the 3-week period prior to the examination.",
                    "timeFrame": "Cycle 1 Day 1 up to 18 weeks or at the 30-day follow-up visit, whichever is earlier (cycle length = 21 days)"
                }
            ],
            "secondaryOutcomes": [
                {
                    "measure": "Number of Participants With All Ocular TEAEs in Participants Using Corticosteroid Versus Vasoconstricting Eye Drop Primary Prophylaxis",
                    "timeFrame": "Cycle 1 Day 1 up to 18 weeks or at the 30-day follow-up visit, whichever is earlier (cycle length = 21 days)"
                },
                {
                    "measure": "Number of Participants With MIRV-related Corneal AEs and All Ocular TEAEs in Asymptomatic Versus Symptomatic Participants",
                    "timeFrame": "Cycle 1 Day 1 up to 18 weeks or at the 30-day follow-up visit, whichever is earlier (cycle length = 21 days)"
                },
                {
                    "measure": "Number of Participants With MIRV-related Corneal AEs and All Ocular TEAEs in Participants Using Corticosteroid Versus Vasoconstricting Eye Drop Primary Prophylaxis",
                    "timeFrame": "Cycle 1 Day 1 up to 18 weeks or at the 30-day follow-up visit, whichever is earlier (cycle length = 21 days)"
                },
                {
                    "measure": "National Eye Institute Visual Function Questionnaire-25 (NEI VFQ-25) Composite Score",
                    "timeFrame": "At Cycle 5 Day 1 or at the 30-day follow-up visit, whichever is earlier (cycle length = 21 days)"
                },
                {
                    "measure": "Area Under the Curve (AUC) of MIRV",
                    "timeFrame": "Day 1 and Day 8 of Cycles 1 through 4 up to 18 weeks or at the 30-day follow-up visit, whichever is earlier (cycle length = 21 days)"
                },
                {
                    "measure": "Maximum Serum Concentration (Cmax) of MIRV",
                    "timeFrame": "Day 1 and Day 8 of Cycles 1 through 4 up to 18 weeks or at the 30-day follow-up visit, whichever is earlier (cycle length = 21 days)"
                },
                {
                    "measure": "Trough Concentration (Ctrough) of MIRV",
                    "timeFrame": "Day 1 and Day 8 of Cycles 1 through 4 up to 18 weeks or at the 30-day follow-up visit, whichever is earlier (cycle length = 21 days)"
                }
            ]
        },
        "eligibilityModule": {
            "eligibilityCriteria": "Key Inclusion Criteria:\n\n* Participants must have a confirmed diagnosis of epithelial ovarian, fallopian tube, and primary peritoneal cancer (EOC) with high FR\u03b1 expression.\n* Participant's tumor must be FR\u03b1 positive (FR\u03b1 high) as defined by either the Ventana folate receptor 1 (FOLR1) (FOLR1-2.1) CDX Assay or Ventana FOLR1 (FOLR1-2.1) RxDx Assay (hereafter collectively termed: Ventana FOLR1 Assay) (\u226575% cells exhibit 2 or 3+ membrane-staining intensity).\n* Participants with known breast cancer susceptibility gene (BRCA) mutations (tumor or germline) must have received poly (ADP-ribose) polymerase inhibitors (PARPi).\n* Participants must have completed prior therapy within the specified times below:\n\n  1. Systemic antineoplastic therapy \u2265 5 half-lives or 4 weeks (whichever is shorter) prior to first dose of MIRV;\n  2. Focal radiation completed \u2265 2 weeks prior to the first dose of MIRV.\n* Participants must have stabilized or recovered (Grade 1 or baseline) from all prior therapy-related toxicities (except alopecia).\n* Women of childbearing potential (WOCBP) must agree to use highly effective contraceptive method(s) while on MIRV and for \u2265 7 months after the last dose; and must have a negative pregnancy test \u2264 4 days prior to the first dose of MIRV.\n\nKey Exclusion Criteria:\n\n* Participants with borderline ovarian tumor or non-epithelial histology or mixed histology including borderline or non-epithelial histology will be excluded.\n* PROC participants with primary platinum-refractory disease, defined as disease that did not respond to (complete response \\[CR\\] or partial response \\[PR\\]) or progressed \u2264 3 months of the last dose of first line platinum-containing chemotherapy.\n* Participants with \\> Grade 1 peripheral neuropathy per National Cancer Institute-Common Terminology Criteria for Adverse Events version 5.0 (NCI-CTCAE v5.0).\n* Participants with significant active or chronic corneal disorders (for example, corneal dystrophies, degenerations, limbal stem cell deficiency), history of corneal transplantation, significant ocular inflammatory conditions (for example, active or recurrent uveitis), or other active ocular conditions requiring ongoing treatment/monitoring, such as uncontrolled glaucoma, active diabetic retinopathy with macular edema, macular degeneration requiring treatment \u2264 90 days prior to first dose, presence of papilledema, best corrected visual acuity (BCVA) worse than 20/70, or monocular vision.\n* Participants receiving corticosteroid or vasoconstricting eyedrops at baseline or within 5 weeks of Cycle 1 Day 1.\n* Participants who received prior treatment with MIRV or other FR\u03b1-targeting agents.\n\nNote: Other protocol-defined inclusion and exclusion criteria may apply.",
            "healthyVolunteers": false,
            "sex": "FEMALE",
            "minimumAge": "18 Years",
            "stdAges": [
                "ADULT",
                "OLDER_ADULT"
            ]
        },
        "contactsLocationsModule": {
            "centralContacts": [
                {
                    "name": "ImmunoGen, Inc.",
                    "role": "CONTACT",
                    "phone": "781-895-0600",
                    "email": "424medical@immunogen.com"
                }
            ],
            "overallOfficials": [
                {
                    "name": "Sheri Spunt, MD",
                    "affiliation": "ImmunoGen, Inc.",
                    "role": "STUDY_DIRECTOR"
                }
            ],
            "locations": [
                {
                    "facility": "University of Colorado Health - University of Colorado Cancer Center (UCCC) - Anschutz Medical Campus (Anschutz Cancer Pavilion) (ACP)",
                    "city": "Aurora",
                    "state": "Colorado",
                    "zip": "80045",
                    "country": "United States",
                    "geoPoint": {
                        "lat": 39.72943,
                        "lon": -104.83192
                    }
                },
                {
                    "facility": "Yale School of Medicine - Yale Gynecologic Oncology",
                    "city": "New Haven",
                    "state": "Connecticut",
                    "zip": "06510",
                    "country": "United States",
                    "geoPoint": {
                        "lat": 41.30815,
                        "lon": -72.92816
                    }
                },
                {
                    "facility": "Holy Cross Hospital",
                    "city": "Silver Spring",
                    "state": "Maryland",
                    "zip": "20910",
                    "country": "United States",
                    "geoPoint": {
                        "lat": 38.99067,
                        "lon": -77.02609
                    }
                },
                {
                    "facility": "Baystate Regional Cancer Program - D'Amour Center for Cancer Care Location - Gynecologic Oncology",
                    "city": "Springfield",
                    "state": "Massachusetts",
                    "zip": "01107",
                    "country": "United States",
                    "geoPoint": {
                        "lat": 42.10148,
                        "lon": -72.58981
                    }
                },
                {
                    "facility": "New York Oncology Hematology",
                    "city": "Albany",
                    "state": "New York",
                    "zip": "12208",
                    "country": "United States",
                    "geoPoint": {
                        "lat": 42.65258,
                        "lon": -73.75623
                    }
                },
                {
                    "facility": "Women's Cancer Care Associates, LLC",
                    "city": "Albany",
                    "state": "New York",
                    "zip": "12208",
                    "country": "United States",
                    "geoPoint": {
                        "lat": 42.65258,
                        "lon": -73.75623
                    }
                },
                {
                    "facility": "New York-Presbyterian/Columbia University Medical Center - Herbert Irving Comprehensive Cancer Center (HICCC) - Herbert Irving Pavilion",
                    "city": "New York",
                    "state": "New York",
                    "zip": "10032",
                    "country": "United States",
                    "geoPoint": {
                        "lat": 40.71427,
                        "lon": -74.00597
                    }
                },
                {
                    "facility": "Duke Cancer Institute (DCI) - Duke Cancer Center",
                    "city": "Durham",
                    "state": "North Carolina",
                    "zip": "27710",
                    "country": "United States",
                    "geoPoint": {
                        "lat": 35.99403,
                        "lon": -78.89862
                    }
                },
                {
                    "facility": "University of Texas Southwestern Medical Center - Harold C. Simmons Comprehensive Cancer Center - University Hospital Gynecologic Oncology Clinic",
                    "city": "Dallas",
                    "state": "Texas",
                    "zip": "75235",
                    "country": "United States",
                    "geoPoint": {
                        "lat": 32.78306,
                        "lon": -96.80667
                    }
                },
                {
                    "facility": "Monash University - Monash Medical Centre (MMC) - Clayton",
                    "city": "Clayton",
                    "state": "Victoria",
                    "country": "Australia",
                    "geoPoint": {
                        "lat": -37.91667,
                        "lon": 145.11667
                    }
                },
                {
                    "facility": "Universitair Ziekenhuis Antwerpen (UZA) - Borstkliniek",
                    "city": "Edegem",
                    "state": "Antwerp",
                    "country": "Belgium",
                    "geoPoint": {
                        "lat": 51.15662,
                        "lon": 4.44504
                    }
                },
                {
                    "facility": "AZ Sint-Lucas - Campus Sint-Lucas - Borstkliniek",
                    "city": "Gent",
                    "state": "East Flanders",
                    "country": "Belgium",
                    "geoPoint": {
                        "lat": 51.05,
                        "lon": 3.71667
                    }
                },
                {
                    "facility": "Universitair Ziekenhuis Gent (UZ Gent)",
                    "city": "Gent",
                    "state": "East Flanders",
                    "country": "Belgium",
                    "geoPoint": {
                        "lat": 51.05,
                        "lon": 3.71667
                    }
                },
                {
                    "facility": "McGill University Health Centre (MUHC) - The Montreal General Hospital (MGH) - Cedars Cancer Centre",
                    "city": "Montreal",
                    "state": "Quebec",
                    "country": "Canada",
                    "geoPoint": {
                        "lat": 45.50884,
                        "lon": -73.58781
                    }
                },
                {
                    "facility": "Universite de Montreal - Centre Hospitalier de l'Universite de Montreal (CHUM) - Hopital Notre-Dame",
                    "city": "Montreal",
                    "state": "Quebec",
                    "country": "Canada",
                    "geoPoint": {
                        "lat": 45.50884,
                        "lon": -73.58781
                    }
                },
                {
                    "facility": "Assistance Publique-Hopitaux de Paris (AP-HP) - Hopital Cochin",
                    "city": "Paris",
                    "country": "France",
                    "geoPoint": {
                        "lat": 48.85341,
                        "lon": 2.3488
                    }
                },
                {
                    "facility": "Groupe Hospitalier Diaconesses Croix Saint-Simon - Hopital de la Croix Saint-Simon",
                    "city": "Paris",
                    "country": "France",
                    "geoPoint": {
                        "lat": 48.85341,
                        "lon": 2.3488
                    }
                },
                {
                    "facility": "Hospices Civils de Lyon (HCL) - Centre Hospitalier Lyon-Sud",
                    "city": "Pierre Benite",
                    "country": "France",
                    "geoPoint": {
                        "lat": 45.7009,
                        "lon": 4.82511
                    }
                },
                {
                    "facility": "Bon Secours Hospital - Dublin",
                    "city": "Dublin",
                    "country": "Ireland",
                    "geoPoint": {
                        "lat": 53.33306,
                        "lon": -6.24889
                    }
                },
                {
                    "facility": "Mater Misericordiae University Hospital (MMUH) (START Dublin)",
                    "city": "Dublin",
                    "country": "Ireland",
                    "geoPoint": {
                        "lat": 53.33306,
                        "lon": -6.24889
                    }
                },
                {
                    "facility": "Istituto Europeo di Oncologia (IEO) (European Institute of Oncology)",
                    "city": "Milan",
                    "country": "Italy",
                    "geoPoint": {
                        "lat": 45.46427,
                        "lon": 9.18951
                    }
                },
                {
                    "facility": "Institut Catala d'Oncologia (ICO) - Hospital Universitari Germans Trias i Pujol (HUGTP) Location",
                    "city": "Badalona",
                    "state": "Barcelona",
                    "country": "Spain",
                    "geoPoint": {
                        "lat": 41.45004,
                        "lon": 2.24741
                    }
                },
                {
                    "facility": "Parc Taul\u00ed",
                    "city": "Barcelona",
                    "country": "Spain",
                    "geoPoint": {
                        "lat": 41.38879,
                        "lon": 2.15899
                    }
                },
                {
                    "facility": "Vall d'Hebron Institut d'Oncologia",
                    "city": "Barcelona",
                    "country": "Spain",
                    "geoPoint": {
                        "lat": 41.38879,
                        "lon": 2.15899
                    }
                },
                {
                    "facility": "Complejo Hospitalario de Jaen (University Hospital Ciudad De Jaen)",
                    "city": "Jaen",
                    "country": "Spain",
                    "geoPoint": {
                        "lat": 37.76922,
                        "lon": -3.79028
                    }
                }
            ]
        },
        "ipdSharingStatementModule": {
            "ipdSharing": "NO"
        }
    },
    "derivedSection": {
        "miscInfoModule": {
            "versionHolder": "2024-07-30"
        },
        "conditionBrowseModule": {
            "meshes": [
                {
                    "id": "D000010051",
                    "term": "Ovarian Neoplasms"
                },
                {
                    "id": "D000077216",
                    "term": "Carcinoma, Ovarian Epithelial"
                },
                {
                    "id": "D000081028",
                    "term": "Toxic Optic Neuropathy"
                },
                {
                    "id": "D000012008",
                    "term": "Recurrence"
                }
            ],
            "ancestors": [
                {
                    "id": "D000020969",
                    "term": "Disease Attributes"
                },
                {
                    "id": "D000010335",
                    "term": "Pathologic Processes"
                },
                {
                    "id": "D000004701",
                    "term": "Endocrine Gland Neoplasms"
                },
                {
                    "id": "D000009371",
                    "term": "Neoplasms by Site"
                },
                {
                    "id": "D000009369",
                    "term": "Neoplasms"
                },
                {
                    "id": "D000010049",
                    "term": "Ovarian Diseases"
                },
                {
                    "id": "D000000291",
                    "term": "Adnexal Diseases"
                },
                {
                    "id": "D000005831",
                    "term": "Genital Diseases, Female"
                },
                {
                    "id": "D000052776",
                    "term": "Female Urogenital Diseases"
                },
                {
                    "id": "D000005261",
                    "term": "Female Urogenital Diseases and Pregnancy Complications"
                },
                {
                    "id": "D000091642",
                    "term": "Urogenital Diseases"
                },
                {
                    "id": "D000005833",
                    "term": "Genital Neoplasms, Female"
                },
                {
                    "id": "D000014565",
                    "term": "Urogenital Neoplasms"
                },
                {
                    "id": "D000091662",
                    "term": "Genital Diseases"
                },
                {
                    "id": "D000004700",
                    "term": "Endocrine System Diseases"
                },
                {
                    "id": "D000006058",
                    "term": "Gonadal Disorders"
                },
                {
                    "id": "D000002277",
                    "term": "Carcinoma"
                },
                {
                    "id": "D000009375",
                    "term": "Neoplasms, Glandular and Epithelial"
                },
                {
                    "id": "D000009370",
                    "term": "Neoplasms by Histologic Type"
                },
                {
                    "id": "D000020221",
                    "term": "Optic Nerve Injuries"
                },
                {
                    "id": "D000020209",
                    "term": "Cranial Nerve Injuries"
                },
                {
                    "id": "D000003389",
                    "term": "Cranial Nerve Diseases"
                },
                {
                    "id": "D000009422",
                    "term": "Nervous System Diseases"
                },
                {
                    "id": "D000009901",
                    "term": "Optic Nerve Diseases"
                },
                {
                    "id": "D000006259",
                    "term": "Craniocerebral Trauma"
                },
                {
                    "id": "D000020196",
                    "term": "Trauma, Nervous System"
                },
                {
                    "id": "D000005128",
                    "term": "Eye Diseases"
                },
                {
                    "id": "D000064420",
                    "term": "Drug-Related Side Effects and Adverse Reactions"
                },
                {
                    "id": "D000064419",
                    "term": "Chemically-Induced Disorders"
                },
                {
                    "id": "D000011832",
                    "term": "Radiation Injuries"
                },
                {
                    "id": "D000014947",
                    "term": "Wounds and Injuries"
                }
            ],
            "browseLeaves": [
                {
                    "id": "M14850",
                    "name": "Recurrence",
                    "asFound": "Recurrent",
                    "relevance": "HIGH"
                },
                {
                    "id": "M12974",
                    "name": "Ovarian Neoplasms",
                    "asFound": "Ovarian Cancer",
                    "relevance": "HIGH"
                },
                {
                    "id": "M1704",
                    "name": "Carcinoma, Ovarian Epithelial",
                    "asFound": "Ovarian Cancer",
                    "relevance": "HIGH"
                },
                {
                    "id": "M5534",
                    "name": "Carcinoma",
                    "relevance": "LOW"
                },
                {
                    "id": "M12832",
                    "name": "Optic Nerve Diseases",
                    "relevance": "LOW"
                },
                {
                    "id": "M2260",
                    "name": "Toxic Optic Neuropathy",
                    "asFound": "Ocular Toxicity",
                    "relevance": "HIGH"
                },
                {
                    "id": "M22700",
                    "name": "Disease Attributes",
                    "relevance": "LOW"
                },
                {
                    "id": "M7863",
                    "name": "Endocrine Gland Neoplasms",
                    "relevance": "LOW"
                },
                {
                    "id": "M12972",
                    "name": "Ovarian Diseases",
                    "relevance": "LOW"
                },
                {
                    "id": "M3643",
                    "name": "Adnexal Diseases",
                    "relevance": "LOW"
                },
                {
                    "id": "M8943",
                    "name": "Genital Diseases, Female",
                    "relevance": "LOW"
                },
                {
                    "id": "M2876",
                    "name": "Genital Diseases",
                    "relevance": "LOW"
                },
                {
                    "id": "M2875",
                    "name": "Urogenital Diseases",
                    "relevance": "LOW"
                },
                {
                    "id": "M27093",
                    "name": "Female Urogenital Diseases",
                    "relevance": "LOW"
                },
                {
                    "id": "M14127",
                    "name": "Pregnancy Complications",
                    "relevance": "LOW"
                },
                {
                    "id": "M8399",
                    "name": "Female Urogenital Diseases and Pregnancy Complications",
                    "relevance": "LOW"
                },
                {
                    "id": "M8945",
                    "name": "Genital Neoplasms, Female",
                    "relevance": "LOW"
                },
                {
                    "id": "M17315",
                    "name": "Urogenital Neoplasms",
                    "relevance": "LOW"
                },
                {
                    "id": "M7862",
                    "name": "Endocrine System Diseases",
                    "relevance": "LOW"
                },
                {
                    "id": "M9163",
                    "name": "Gonadal Disorders",
                    "relevance": "LOW"
                },
                {
                    "id": "M12320",
                    "name": "Neoplasms, Glandular and Epithelial",
                    "relevance": "LOW"
                },
                {
                    "id": "M12315",
                    "name": "Neoplasms by Histologic Type",
                    "relevance": "LOW"
                },
                {
                    "id": "M22047",
                    "name": "Optic Nerve Injuries",
                    "relevance": "LOW"
                },
                {
                    "id": "M22036",
                    "name": "Cranial Nerve Injuries",
                    "relevance": "LOW"
                },
                {
                    "id": "M6605",
                    "name": "Cranial Nerve Diseases",
                    "relevance": "LOW"
                },
                {
                    "id": "M17685",
                    "name": "Wounds and Injuries",
                    "relevance": "LOW"
                },
                {
                    "id": "M9349",
                    "name": "Craniocerebral Trauma",
                    "relevance": "LOW"
                },
                {
                    "id": "M22023",
                    "name": "Trauma, Nervous System",
                    "relevance": "LOW"
                },
                {
                    "id": "M8271",
                    "name": "Eye Diseases",
                    "relevance": "LOW"
                },
                {
                    "id": "M30303",
                    "name": "Drug-Related Side Effects and Adverse Reactions",
                    "relevance": "LOW"
                },
                {
                    "id": "M30302",
                    "name": "Chemically-Induced Disorders",
                    "relevance": "LOW"
                },
                {
                    "id": "M14679",
                    "name": "Radiation Injuries",
                    "relevance": "LOW"
                },
                {
                    "id": "T4352",
                    "name": "Ovarian Cancer",
                    "asFound": "Ovarian Cancer",
                    "relevance": "HIGH"
                },
                {
                    "id": "T4354",
                    "name": "Ovarian Epithelial Cancer",
                    "asFound": "Ovarian Cancer",
                    "relevance": "HIGH"
                }
            ],
            "browseBranches": [
                {
                    "abbrev": "BC23",
                    "name": "Symptoms and General Pathology"
                },
                {
                    "abbrev": "All",
                    "name": "All Conditions"
                },
                {
                    "abbrev": "BC04",
                    "name": "Neoplasms"
                },
                {
                    "abbrev": "BXS",
                    "name": "Urinary Tract, Sexual Organs, and Pregnancy Conditions"
                },
                {
                    "abbrev": "BC19",
                    "name": "Gland and Hormone Related Diseases"
                },
                {
                    "abbrev": "BC10",
                    "name": "Nervous System Diseases"
                },
                {
                    "abbrev": "BC11",
                    "name": "Eye Diseases"
                },
                {
                    "abbrev": "BC25",
                    "name": "Substance Related Disorders"
                },
                {
                    "abbrev": "BC26",
                    "name": "Wounds and Injuries"
                },
                {
                    "abbrev": "Rare",
                    "name": "Rare Diseases"
                }
            ]
        },
        "interventionBrowseModule": {
            "meshes": [
                {
                    "id": "D000011239",
                    "term": "Prednisolone"
                },
                {
                    "id": "D000077555",
                    "term": "Methylprednisolone Acetate"
                },
                {
                    "id": "D000008775",
                    "term": "Methylprednisolone"
                },
                {
                    "id": "D000008776",
                    "term": "Methylprednisolone Hemisuccinate"
                },
                {
                    "id": "C000009935",
                    "term": "Prednisolone acetate"
                },
                {
                    "id": "D000008453",
                    "term": "Maytansine"
                },
                {
                    "id": "D000068438",
                    "term": "Brimonidine Tartrate"
                },
                {
                    "id": "D000009883",
                    "term": "Ophthalmic Solutions"
                },
                {
                    "id": "D000065346",
                    "term": "Lubricant Eye Drops"
                },
                {
                    "id": "C000021322",
                    "term": "Prednisolone hemisuccinate"
                },
                {
                    "id": "C000009022",
                    "term": "Prednisolone phosphate"
                },
                {
                    "id": "C000607289",
                    "term": "Mirvetuximab soravtansine"
                }
            ],
            "ancestors": [
                {
                    "id": "D000019999",
                    "term": "Pharmaceutical Solutions"
                },
                {
                    "id": "D000000893",
                    "term": "Anti-Inflammatory Agents"
                },
                {
                    "id": "D000005938",
                    "term": "Glucocorticoids"
                },
                {
                    "id": "D000006728",
                    "term": "Hormones"
                },
                {
                    "id": "D000006730",
                    "term": "Hormones, Hormone Substitutes, and Hormone Antagonists"
                },
                {
                    "id": "D000045505",
                    "term": "Physiological Effects of Drugs"
                },
                {
                    "id": "D000018931",
                    "term": "Antineoplastic Agents, Hormonal"
                },
                {
                    "id": "D000000970",
                    "term": "Antineoplastic Agents"
                },
                {
                    "id": "D000000932",
                    "term": "Antiemetics"
                },
                {
                    "id": "D000001337",
                    "term": "Autonomic Agents"
                },
                {
                    "id": "D000018373",
                    "term": "Peripheral Nervous System Agents"
                },
                {
                    "id": "D000005765",
                    "term": "Gastrointestinal Agents"
                },
                {
                    "id": "D000018696",
                    "term": "Neuroprotective Agents"
                },
                {
                    "id": "D000020011",
                    "term": "Protective Agents"
                },
                {
                    "id": "D000000959",
                    "term": "Antihypertensive Agents"
                },
                {
                    "id": "D000058647",
                    "term": "Adrenergic alpha-2 Receptor Agonists"
                },
                {
                    "id": "D000000316",
                    "term": "Adrenergic alpha-Agonists"
                },
                {
                    "id": "D000000322",
                    "term": "Adrenergic Agonists"
                },
                {
                    "id": "D000018663",
                    "term": "Adrenergic Agents"
                },
                {
                    "id": "D000018377",
                    "term": "Neurotransmitter Agents"
                },
                {
                    "id": "D000045504",
                    "term": "Molecular Mechanisms of Pharmacological Action"
                },
                {
                    "id": "D000018796",
                    "term": "Immunoconjugates"
                },
                {
                    "id": "D000007155",
                    "term": "Immunologic Factors"
                },
                {
                    "id": "D000000972",
                    "term": "Antineoplastic Agents, Phytogenic"
                },
                {
                    "id": "D000050257",
                    "term": "Tubulin Modulators"
                },
                {
                    "id": "D000050256",
                    "term": "Antimitotic Agents"
                },
                {
                    "id": "D000050258",
                    "term": "Mitosis Modulators"
                }
            ],
            "browseLeaves": [
                {
                    "id": "M4225",
                    "name": "Antibodies",
                    "relevance": "LOW"
                },
                {
                    "id": "M11749",
                    "name": "Methylprednisolone",
                    "asFound": "Fenofibrate",
                    "relevance": "HIGH"
                },
                {
                    "id": "M1833",
                    "name": "Methylprednisolone Acetate",
                    "asFound": "Fenofibrate",
                    "relevance": "HIGH"
                },
                {
                    "id": "M11750",
                    "name": "Methylprednisolone Hemisuccinate",
                    "asFound": "Fenofibrate",
                    "relevance": "HIGH"
                },
                {
                    "id": "M14120",
                    "name": "Prednisolone",
                    "asFound": "Determined",
                    "relevance": "HIGH"
                },
                {
                    "id": "M229449",
                    "name": "Prednisolone acetate",
                    "asFound": "Fenofibrate",
                    "relevance": "HIGH"
                },
                {
                    "id": "M211887",
                    "name": "Prednisolone hemisuccinate",
                    "asFound": "Fenofibrate",
                    "relevance": "HIGH"
                },
                {
                    "id": "M248881",
                    "name": "Prednisolone phosphate",
                    "asFound": "Fenofibrate",
                    "relevance": "HIGH"
                },
                {
                    "id": "M21860",
                    "name": "Pharmaceutical Solutions",
                    "relevance": "LOW"
                },
                {
                    "id": "M17546",
                    "name": "Vitamin B Complex",
                    "relevance": "LOW"
                },
                {
                    "id": "M8618",
                    "name": "Folic Acid",
                    "relevance": "LOW"
                },
                {
                    "id": "M12814",
                    "name": "Ophthalmic Solutions",
                    "asFound": "Cerebral",
                    "relevance": "HIGH"
                },
                {
                    "id": "M10184",
                    "name": "Immunoglobulins",
                    "relevance": "LOW"
                },
                {
                    "id": "M4230",
                    "name": "Antibodies, Monoclonal",
                    "relevance": "LOW"
                },
                {
                    "id": "M30506",
                    "name": "Lubricant Eye Drops",
                    "asFound": "Thyroid gland",
                    "relevance": "HIGH"
                },
                {
                    "id": "M265",
                    "name": "Brimonidine Tartrate",
                    "asFound": "ABC",
                    "relevance": "HIGH"
                },
                {
                    "id": "M288583",
                    "name": "Mirvetuximab soravtansine",
                    "asFound": "Abdominal binder",
                    "relevance": "HIGH"
                },
                {
                    "id": "M11436",
                    "name": "Maytansine",
                    "asFound": "Respiratory system",
                    "relevance": "HIGH"
                },
                {
                    "id": "M4217",
                    "name": "Anti-Inflammatory Agents",
                    "relevance": "LOW"
                },
                {
                    "id": "M9047",
                    "name": "Glucocorticoids",
                    "relevance": "LOW"
                },
                {
                    "id": "M9789",
                    "name": "Hormones",
                    "relevance": "LOW"
                },
                {
                    "id": "M9788",
                    "name": "Hormone Antagonists",
                    "relevance": "LOW"
                },
                {
                    "id": "M20966",
                    "name": "Antineoplastic Agents, Hormonal",
                    "relevance": "LOW"
                },
                {
                    "id": "M4251",
                    "name": "Antiemetics",
                    "relevance": "LOW"
                },
                {
                    "id": "M8881",
                    "name": "Gastrointestinal Agents",
                    "relevance": "LOW"
                },
                {
                    "id": "M20773",
                    "name": "Neuroprotective Agents",
                    "relevance": "LOW"
                },
                {
                    "id": "M21869",
                    "name": "Protective Agents",
                    "relevance": "LOW"
                },
                {
                    "id": "M4277",
                    "name": "Antihypertensive Agents",
                    "relevance": "LOW"
                },
                {
                    "id": "M20746",
                    "name": "Adrenergic Agents",
                    "relevance": "LOW"
                },
                {
                    "id": "M3668",
                    "name": "Adrenergic alpha-Agonists",
                    "relevance": "LOW"
                },
                {
                    "id": "M3673",
                    "name": "Adrenergic Agonists",
                    "relevance": "LOW"
                },
                {
                    "id": "M20504",
                    "name": "Neurotransmitter Agents",
                    "relevance": "LOW"
                },
                {
                    "id": "M20855",
                    "name": "Immunoconjugates",
                    "relevance": "LOW"
                },
                {
                    "id": "M10201",
                    "name": "Immunologic Factors",
                    "relevance": "LOW"
                },
                {
                    "id": "M26197",
                    "name": "Tubulin Modulators",
                    "relevance": "LOW"
                },
                {
                    "id": "M26196",
                    "name": "Antimitotic Agents",
                    "relevance": "LOW"
                },
                {
                    "id": "T446",
                    "name": "Folic Acid",
                    "relevance": "LOW"
                },
                {
                    "id": "T447",
                    "name": "Folinic Acid",
                    "relevance": "LOW"
                },
                {
                    "id": "T448",
                    "name": "Folate",
                    "relevance": "LOW"
                },
                {
                    "id": "T475",
                    "name": "Vitamin B9",
                    "relevance": "LOW"
                }
            ],
            "browseBranches": [
                {
                    "abbrev": "All",
                    "name": "All Drugs and Chemicals"
                },
                {
                    "abbrev": "Infl",
                    "name": "Anti-Inflammatory Agents"
                },
                {
                    "abbrev": "AnEm",
                    "name": "Antiemetics"
                },
                {
                    "abbrev": "NeuroAg",
                    "name": "Neuroprotective Agents"
                },
                {
                    "abbrev": "Gast",
                    "name": "Gastrointestinal Agents"
                },
                {
                    "abbrev": "ANeo",
                    "name": "Antineoplastic Agents"
                },
                {
                    "abbrev": "PhSol",
                    "name": "Pharmaceutical Solutions"
                },
                {
                    "abbrev": "Micro",
                    "name": "Micronutrients"
                },
                {
                    "abbrev": "Hemat",
                    "name": "Hematinics"
                },
                {
                    "abbrev": "AnAg",
                    "name": "Antihypertensive Agents"
                },
                {
                    "abbrev": "Vi",
                    "name": "Vitamins"
                }
            ]
        }
    },
    "hasResults": false
}